Lv3
268 积分 2023-05-15 加入
Comparison of obinutuzumab and rituximab for treating primary membranous nephropathy
3天前
已完结
Obinutuzumab in untreated primary membranous nephropathy: An observational case series
10天前
已完结
Combined Serologic and Genetic Risk Score and Prognostication of Phospholipase A2 receptor-Associated Membranous Nephropathy
10天前
已完结
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
26天前
已关闭
CD20: a regulator of cell-cycle progression of B lymphocytes
26天前
已完结
Development of a time-resolved fluoroimmunoassay for rituximab and its application to therapeutic drug monitoring
26天前
已完结
Response to “Association Between Dietary Potassium Intake and Serum Potassium in CKD”
1个月前
已完结
Stakeholder Power Analysis of the Facilitators and Barriers for Telehealth Solution Implementation in China: A Qualitative Study of Individual Users in Beijing and Interviews With Institutional Stakeholders
1个月前
已完结
Immune-related acute kidney injury in Australian non-small cell lung cancer patients: Real-world results
1个月前
已完结
Chronic Tonsillitis and IgA Nephropathy: Findings From a Nationwide Japanese Cohort Study
1个月前
已完结
皖公网安备34019202002308
